{"entity":{"type":"insider","cik":"0001682735","url":"/insider/0001682735","json_url":"/insider/0001682735.json","name":"Peterson Amy C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":7,"first":"2017-11-15","last":"2025-05-16","span_basis":"filed_date"},"name_variants":[{"name":"Peterson Amy C.","source":"filing","n_filings":7,"first_seen":"2017-11-15","last_seen":"2025-05-16"}],"transactions":[{"id":4227345,"accession":"0000939767-25-000076","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000939767-25-000076","line_url":"/filing/0000939767-25-000076#line-3","is_derivative":false,"issuer_cik":"0000939767","issuer_name":"EXELIXIS, INC.","issuer_ticker":"EXEL","issuer_name_source":null,"issuer_url":"/issuer/0000939767","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (EVP Prod Dev & Med Aff & CMO)","role_mark":"O","role_mark_label":"Officer (EVP Prod Dev & Med Aff & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Prod Dev & Med Aff & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72776.0,"shares_display":"72,776","price_per_share":45.47,"price_display":"45.47","price_state":"stated","total_value":3309124.72,"total_display":"3,309,124.72","total_whole":"3,309,125","shares_owned_after":465393.0,"shares_owned_after_display":"465,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-16","scope":"insider"},{"id":8213859,"accession":"0001140361-23-012614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-012614","line_url":"/filing/0001140361-23-012614#line-1","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4257.0,"shares_display":"4,257","price_per_share":1.979,"price_display":"1.98","price_state":"stated","total_value":8424.603,"total_display":"8,424.60","total_whole":"8,425","shares_owned_after":58433.0,"shares_owned_after_display":"58,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider"},{"id":6731819,"accession":"0001567619-22-014301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-014301","line_url":"/filing/0001567619-22-014301#line-2","is_derivative":false,"issuer_cik":"0001501989","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001501989","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7463.0,"shares_display":"7,463","price_per_share":1.422,"price_display":"1.42","price_state":"stated","total_value":10612.386,"total_display":"10,612.39","total_whole":"10,612","shares_owned_after":62690.0,"shares_owned_after_display":"62,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-21","scope":"insider"},{"id":6368417,"accession":"0001651308-18-000018","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001651308-18-000018","line_url":"/filing/0001651308-18-000018","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10141.0,"shares_display":"10,141","price_per_share":133.74539672616112,"price_display":"133.75","price_state":"stated","total_value":1356312.0682,"total_display":"1,356,312.07","total_whole":"1,356,312","shares_owned_after":611.0,"shares_owned_after_display":"611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-19","scope":"insider","n_lines":5},{"id":6368400,"accession":"0001651308-18-000018","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001651308-18-000018","line_url":"/filing/0001651308-18-000018","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9859.0,"shares_display":"9,859","price_per_share":133.60624788518106,"price_display":"133.61","price_state":"stated","total_value":1317223.9979,"total_display":"1,317,224.00","total_whole":"1,317,224","shares_owned_after":6259.0,"shares_owned_after_display":"6,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-19","scope":"insider","n_lines":7},{"id":6674545,"accession":"0001682735-18-000003","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001682735-18-000003","line_url":"/filing/0001682735-18-000003","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12067.0,"shares_display":"12,067","price_per_share":112.73300381204939,"price_display":"112.73","price_state":"stated","total_value":1360349.157,"total_display":"1,360,349.16","total_whole":"1,360,349","shares_owned_after":5109.0,"shares_owned_after_display":"5,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-12","filed_date":"2018-11-13","scope":"insider","n_lines":8},{"id":6674521,"accession":"0001682735-18-000003","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001682735-18-000003","line_url":"/filing/0001682735-18-000003","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13222.0,"shares_display":"13,222","price_per_share":120.49332356678264,"price_display":"120.49","price_state":"stated","total_value":1593162.7242,"total_display":"1,593,162.72","total_whole":"1,593,163","shares_owned_after":9191.0,"shares_owned_after_display":"9,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-13","scope":"insider","n_lines":7},{"id":6674501,"accession":"0001682735-18-000003","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001682735-18-000003","line_url":"/filing/0001682735-18-000003","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14711.0,"shares_display":"14,711","price_per_share":126.06738158520835,"price_display":"126.07","price_state":"stated","total_value":1854577.2505,"total_display":"1,854,577.25","total_whole":"1,854,577","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-13","scope":"insider","n_lines":5},{"id":6312856,"accession":"0001179110-18-010878","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-18-010878","line_url":"/filing/0001179110-18-010878","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5769.0,"shares_display":"5,769","price_per_share":169.1222838273531,"price_display":"169.12","price_state":"stated","total_value":975666.4554,"total_display":"975,666.46","total_whole":"975,666","shares_owned_after":2361.0,"shares_owned_after_display":"2,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-24","scope":"insider","n_lines":4},{"id":4474148,"accession":"0001179110-17-014170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-014170","line_url":"/filing/0001179110-17-014170","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001682735","owner_name":"Peterson Amy C.","owner_display_name":"Peterson Amy C.","owner_url":"/insider/0001682735","role":"Officer (CMO, Immuno-oncology)","role_mark":"O","role_mark_label":"Officer (CMO, Immuno-oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, Immuno-oncology","security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3601.0,"shares_display":"3,601","price_per_share":82.96226301027492,"price_display":"82.96","price_state":"stated","total_value":298747.1091,"total_display":"298,747.11","total_whole":"298,747","shares_owned_after":1201.0,"shares_owned_after_display":"1,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000939767","name":"EXELIXIS, INC.","url":"/issuer/0000939767","role":"Officer (EVP Prod Dev & Med Aff & CMO)","n_filings":1,"first_seen":"2025-05-16","last_seen":"2025-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001501989","name":"CytomX Therapeutics, Inc.","url":"/issuer/0001501989","role":"Officer (EVP, Chief Development Officer)","n_filings":2,"first_seen":"2022-07-21","last_seen":"2023-03-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001651308","name":"BeiGene, Ltd.","url":"/issuer/0001651308","role":"Officer (CMO, Immuno-oncology)","n_filings":4,"first_seen":"2017-11-15","last_seen":"2018-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682735","retrieved_at":"2026-08-25T16:03:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}